Contact Us
TEL: +86-0571-88334626
E-mail: sales@tacon-china.com.cn
Home > News > Content
Clopidogrel Pharmacology
Dec 19, 2018

It is a platelet aggregation inhibitor that selectively inhibits the binding of ADP to platelet receptors and inhibits ADP-mediated activation of glycoprotein GPIIb/IIIa complex, while inhibiting platelet aggregation. Non-ADP-induced platelet aggregation can also be inhibited. The effect on platelet ADP receptors is irreversible. Oral absorption is rapid, the protein binding rate in plasma is 98%, metabolized in the liver, and the main metabolites have no anti-platelet aggregation.